Hypertension

Triple regimen for lowering BP

July 26, 2010

An investigational triple regimen of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) may result in significantly greater mean reductions in...

BP variability may signal cardiovascular events

May 10, 2010

Visit-to-visit variability in systolic BP was more predictive of ischemic stroke than of hemorrhagic stroke.

Study challenges benefits of intensive BP control in patients with diabetes

March 22, 2010

Research shows that intensive BP control does not reduce the rate of a composite outcome of fatal and nonfatal cardiovascular events in patients with type 2 diabetes.

Cocoa can decrease blood pressure

January 11, 2010

Cocoa products such as dark chocolate and cocoa-containing beverages can lower blood pressure, a recent meta-analysis confirms.

Gout drug prevents BP jump in men

December 17, 2009

Allopurinol, which is used to lower uric acid levels to counteract gout, may also reduce BP that has been raised by a diet high in fructose, the only common sugar currently known to increase uric acid levels.

Guidelines: How to treat resistant hypertension

By Carl Sherman May 21, 2009

In its first Scientific Statement to focus on this issue, the American Heart Association stresses the need for evaluation that spreads a broad net to identify contributing and secondary causes and treatment options that go beyond the usual antihypertensives.

Cleviprex

February 05, 2009

An IV calcium channel blocker to reduce BP from The Medicines Company

Ambulatory BP betters office reads for CV risk

By Delicia Yard November 26, 2008

A recent report found that office BP has no value in predicting cardiovascular (CV) morbidity and mortality in patients with resistant hypertension. Higher ambulatory measurements, however, are good indicators of these outcomes, according to the same report.

Secondary heart failure

October 08, 2008

As physicians, we need to remind ourselves that congestive heart failure (CHF) is not a diagnosis but rather a complex of symptoms with one or more of five major causes: myocardial ischemia, valvular heart disease, chronic hypertension, arrhythmias, or cardiomyopathy. Thus, if a patient has symptoms of CHF, the diagnosis would be CHF secondary to one of those five causes.

TITRATING ANTIHYPERTENSIVE MEDS

Question raised by Bhavana Japi, MD, New Hyde Park, N.Y. and answered by Samuel J. Mann, MD September 18, 2008

How soon after starting a patient on an antihypertensive medication should its effects be reviewed and the dosage adjusted?

Sign up for our newsletters

Register now to receive Cortlandt Forum's newsletters. Each week we'll give you something new: Derm Xtra highlights our premier dermatology content; Pulse gives you the latest rundown of what's on our Web site; mid-month, we Spotlight a condition common to your practice; and we round out the month on The Lighter Side—geared to provide you with a few chuckles amidst the ups and downs of clinical practice.